Oppose Part B Payment Demonstration Proposal from CMS IDF initiated an Action Alert on March 26, 2016 in opposition to a proposed two phase experimental payment structure by Medicare that will, in phase 1, reduce provider reimbursement for drugs under Medicare Part B in select zip codes. Immunoglobulin (Ig) is one of the drugs specifically […]
Follow the IDF Blog!We feature news and events related to the primary immunodeficiency community. If you have a story idea, contact us.
Sign-up for Blog Updates
Tag CloudAdvocacy Channel Advocacy Volunteers Awareness Month Baxter International Inc. BioLife Biotest Board of Trustees CSL Behring CSL Plasma CVS Caremark | Coram Specialty Infusion Services Grifols Health Care Costs Healthcare Reform Health Insurance IDF IDF Blue Jeans for Healthy Genes IDF Family Conference Day IDF Retreats IgG America | ASD Healthcare | US Bioservices Immune Deficiency Foundation Immunoglobulin Insurance Insurance Companies Legislation Medicare Medicare IVIG Medicare Part B Octapharma Operation Outreach Patient Meeting PerkinElmer PI PI Community primary immune primary immunodeficiency primary immunodeficiency disease SCID SCIG subcutaneous immunoglobulin Teens Vidara Therapeutics Volunteers Walgreens-IG Therapy Walk for PI Zebras
Stay Informed Through IDF
IDF Social Media